Satellite Events

NZAQ BioFuels Forum

Wednesday 24 March 2010, 12.45-2.30pm, SKYCITY Convention Centre

The New Zealand and Queensland Biotechnology Alliance will be holding a Biofuels Forum at the NZBIO 2010 conference.  This Forum will provide opportunities for the development of Trans-Tasman collaboration in Sustainable Biofuels.

Please note: Lunch will be available for conference attendees. Draft Programme is coming soon.

This Satellite Event will be free for NZBIO 2010 Conference Attendees - click here to register

For people not attending the NZBIO 2010 Conference, you can register through the NZBIO Events Calendar here

Deal & Company Valuation Techniques Workshop - When LEO Bought Peplin - Fair Deal or a Steal? 

Presented by: Shane Storey, Healthcare & Biotechnology Analyst, Wilson HTM

Wednesday 24 March, 4.00-6.00pm, SKYCITY Convention Centre

NZBIO has been open in supporting the Government’s intent to improve the capital markets in New Zealand. The lack of a vibrant capital market and a small listed exchange has seen many of our most promising companies sold off-shore or relocated to countries with deeper capital pools. One of the key issues facing small-cap, high technology equities is the lack of research and specialised analysts.

As such NZBIO is very pleased to have secured Dr Shane Storey, Senior Research Analyst (Life Sciences) Wilson HTM to provide examples of the techniques used by specialised industry analysts, in the context of one of 2009’s most significant Australasian biotechnology acquisitions. This workshop is the first of its type to be run by NZBIO and offers significant value to Chief Executives, Business Development and Commercialisation Managers and Investors alike.

Bronwyn Dilley, Chief Executive, NZBIO

When LEO Pharma acquired Peplin Inc (ASX:PLI) for US$287M in 2009, some investors said: "Is that all?".  In this valuation workshop, Shane Storey (Wilson HTM) hosts an interactive case-study, looking at the LEO-Peplin transaction from an analyst's perspective.  The session will look at the valuation techniques used to value Peplin including discounted cash flow and real options analysis. 

To register click here

No events loaded yet